Catalent to make Levodopa-Induced Dyskinesia for Ph III trials

Related tags Clinical trial

Catalent to make Levodopa-Induced Dyskinesia for Ph III trials
Catalent to make Levodopa-Induced Dyskinesia for Ph III trials
Catalent has been contracted to make supplies of an extended-release drug for Parkinson’s disease (PD) patients set to enter Phase III trials by developer Adamas Pharmaceuticals.

The deal – financial terms of which have not been disclosed – will see Catalant make ADS-5102 (amantadine HCl) for assessment as a treatment for Levodopa-Induced Dyskinesia (LID) in patients with Parkinson’s disease.

Adamas CEO Gregory Went said: “We believe Catalent’s capabilities make them the right choice to support execution of our upcoming clinical trials​.”

This was echoed by Barry Littlejohns, President of Catalent’s Advanced Delivery Technologies business, who said: “Our controlled release formulation expertise and drug delivery technologies will ultimately benefit patients with better treatments.

We are pleased Adamas selected Catalent for the development and supply of ADS-5102 which, if approved, will be the first medical treatment indicated for patients with LID in Parkinson’s disease​.”  

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars